Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
2.
Rev Gastroenterol Mex (Engl Ed) ; 86(4): 378-386, 2021.
Article in English | MEDLINE | ID: mdl-34400118

ABSTRACT

INTRODUCTION AND AIMS: A case series of ten patients that received protocolized care for SARS-CoV-2 infection and developed severe gastrointestinal complications, is presented. The aim of our study was to contribute to the ongoing discussion regarding gastrointestinal complications related to SARS-CoV-2 infection. After reviewing the current literature, ours appears to be the first detailed case series on the topic. MATERIALS AND METHODS: A retrospective filtered search of all patients admitted to our hospital for SARS-CoV-2 infection, who developed severe gastrointestinal complications, was performed. All relevant data on hospital patient management, before and after surgery, were collected from the medical records. RESULTS: Of the 905 patients admitted to our hospital due to SARS-CoV-2 infection, as of August 26, 2020, ten of them developed severe gastrointestinal complications. Seven of those patients were men. There were four cases of perforation of the proximal jejunum, three cases of perforations of the ascending colon, one case of concomitant perforation of the sigmoid colon and terminal ileum, one case of massive intestinal necrosis, and one preoperative death. Three right colectomies, four intestinal resections, one Hartmann's procedure with bowel resection, and one primary repair of the small bowel were performed. The mortality rate of the patients analyzed was 50%. CONCLUSION: Spontaneous bowel perforations and acute mesenteric ischemia are emerging as severe, life-threatening complications in hospitalized SARS-CoV-2 patients. More evidence is needed to identify risk factors, establish preventive measures, and analyze possible adverse effects of the current treatment protocols.


Subject(s)
COVID-19 , Gastrointestinal Diseases , Humans , Male , Rectum , Retrospective Studies , SARS-CoV-2
6.
J Dermatolog Treat ; 32(4): 469-472, 2021 Jun.
Article in English | MEDLINE | ID: mdl-31498706

ABSTRACT

BACKGROUND: Isotretinoin is an efficacious treatment option for severe acne. Although isotretinoin often causes mild liver enzyme elevation, how acne patients should be monitored on isotretinoin therapy is not well characterized. OBJECTIVE: The purpose of this study was to assess the management and clinical outcome of acne patients with abnormal aspartate transaminase (AST) and alanine aminotransferase (ALT) when receiving isotretinoin. METHODS: A retrospective chart review was conducted in acne subjects with abnormal AST and ALT levels receiving isotretinoin. Abnormal liver enzymes were graded using the Common Terminology Criteria for Adverse Events version 5. RESULTS: Of 108 subjects with abnormal liver enzymes, 79 subjects were on isotretinoin 80 mg and 23 subjects were on isotretinoin 40 mg. Most abnormalities were during Month 1 of therapy (48). Of the 122 abnormal Grade 1 AST elevations, 40 normalized, 38 remained in Grade 1, and 1 increased into Grade 2 when a healthcare provider maintained the isotretinoin dose. Of the 102 abnormal Grade 1 ALT levels managed by maintaining the isotretinoin dose, 31 normalized and 38 remained persistently elevated. CONCLUSION: Most mild elevations of isotretinoin therapy do not worsen. Acne patients with isotretinoin may not need continued testing when experiencing low-grade liver enzyme abnormalities.


Subject(s)
Acne Vulgaris/drug therapy , Dermatologic Agents/adverse effects , Isotretinoin/adverse effects , Adolescent , Adult , Alanine Transaminase/metabolism , Aspartate Aminotransferases/metabolism , Dermatologic Agents/therapeutic use , Female , Humans , Isotretinoin/therapeutic use , Liver Function Tests , Male , Retrospective Studies , Treatment Outcome , Young Adult
7.
Rev Gastroenterol Mex ; 86(4): 378-386, 2021.
Article in Spanish | MEDLINE | ID: mdl-38620671

ABSTRACT

Introduction and aims: A case series of ten patients that received protocolized care for SARS-CoV-2 infection and developed severe gastrointestinal complications, is presented. The aim of our study was to contribute to the ongoing discussion regarding gastrointestinal complications related to SARS-CoV-2 infection. After reviewing the current literature, ours appears to be the first detailed case series on the topic. Materials and methods: A retrospective filtered search of all patients admitted to our hospital for SARS-CoV-2 infection, who developed severe gastrointestinal complications, was performed. All relevant data on hospital patient management, before and after surgery, were collected from the medical records. Results: Of the 905 patients admitted to our hospital due to SARS-CoV-2 infection, as of August 26, 2020, ten of them developed severe gastrointestinal complications. Seven of those patients were men. There were four cases of perforation of the proximal jejunum, three cases of perforations of the ascending colon, one case of concomitant perforation of the sigmoid colon and terminal ileum, one case of massive intestinal necrosis, and one preoperative death. Three right colectomies, four intestinal resections, one Hartmann's procedure with bowel resection, and one primary repair of the small bowel were performed. The mortality rate of the patients analyzed was 50%. Conclusion: Spontaneous bowel perforations and acute mesenteric ischemia are emerging as severe, life-threatening complications in hospitalized SARS-CoV-2 patients. More evidence is needed to identify risk factors, establish preventive measures, and analyze possible adverse effects of the current treatment protocols.

8.
Malays J Pathol ; 42(1): 137-141, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32342944

ABSTRACT

INTRODUCTION: Eosinophilic angiocentric fibrosis (EAF) is a rare lesion that predominantly affects the upper respiratory tract. Its etiology is unknown and it has been recently associated with the IgG4- related disease (IgG4-RD) spectrum. To the author's knowledge, this is the sixth case report of the relationship between EAF and IgG4-RD. CASE REPORT: We report the case of a 37-year-old woman with nasal deformity and facial pain. The lesion was surgically excised. Histological examination revealed features of EAF with an IgG4/IgG plasma cell ratio ≷73% and 31 IgG4 stained cells per high power field. No clinical or radiological recurrence was detected during follow-up. Serum IgG4 quantification one year after surgery was within normal limits. DISCUSSION: The relationship between both entities may have therapeutic impact because IgG4-RD of the head and neck has a high remission rate with corticosteroids and immunosuppressive therapy. Additional reports of this infrequent disease are necessary to elucidate appropriate treatment and prognosis.


Subject(s)
Eosinophilia/pathology , Fibrosis/pathology , Immunoglobulin G4-Related Disease/pathology , Nose Diseases/pathology , Adult , Female , Humans
10.
Rev Gastroenterol Mex (Engl Ed) ; 85(3): 235-239, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-31495541

ABSTRACT

INTRODUCTION AND AIM: Abdominal pain in children is a frequent cause of emergency room consultation. An important group of those patients presents with chronic constipation and fecal impaction. Plain abdominal x-ray is widely used for making a diagnosis and ruling out the need for surgical treatment. The present study examined the association between pain intensity and fecal impaction grade. MATERIALS AND METHODS: An analytic cross-sectional study was conducted that compared 2 radiographic scales to determine the association between the grade of fecal impaction observed and abdominal pain intensity in patients that sought medical attention at an emergency service within a 7-month period. The analysis was carried out by 2 different observers, utilizing 2 different radiographic scales to confirm their reproducibility. The degree of interobserver agreement was measured using the Kappa coefficient and the association between abdominal pain and fecal impaction grade was measured through the Spearman correlation coefficient. RESULTS: There was a significant association between pain intensity and the radiographic grade of fecal impaction (P<.05) for the radiographic scale by segments and its interobserver agreement was high, compared with the scale by percentage. CONCLUSIONS: Radiographic scales may be useful in the evaluation and treatment of patients with abdominal pain and constipation. The segmental scale showed less interobserver variability, suggesting its proposal as an alternative in the evaluation and follow-up of patients with chronic constipation.


Subject(s)
Abdominal Pain/etiology , Constipation/complications , Fecal Impaction/complications , Fecal Impaction/diagnostic imaging , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Emergency Medical Services , Female , Humans , Infant , Male , Radiography
11.
Br J Dermatol ; 182(1): 8-9, 2020 01.
Article in English | MEDLINE | ID: mdl-31407325
12.
Obes Surg ; 30(2): 640-656, 2020 02.
Article in English | MEDLINE | ID: mdl-31664653

ABSTRACT

BACKGROUND: The most commonly performed bariatric procedures are laparoscopic Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (LSG). Impact of learning curves on operative outcome has been well shown, but the necessary learning curves have not been clearly defined. This study provides a systematic review of the literature and proposes a standardization of phases of learning curves for RYGB and LSG. METHODS: A systematic literature search was performed using PubMed, Web of Science, and CENTRAL databases. All studies specifying a number or range of approaches to characterize the learning curve for RYGB and LSG were selected. RESULTS: A total of 28 publications related to learning curves for 27,770 performed bariatric surgeries were included. Parameters used to determine the learning curve were operative time, complications, conversions, length of stay, and blood loss. Learning curve range was 30-500 (RYGB) and 30-200 operations (LSG) according to different definitions and respective phases of learning curves. Learning phases described the number of procedures necessary to achieve predefined skill levels, such as competency, proficiency, and mastery. CONCLUSIONS: Definitions of learning curves for bariatric surgery are heterogeneous. Introduction of the three skill phases competency, proficiency, and mastery is proposed to provide a standardized definition using multiple outcome variables to enable better comparison in the future. These levels are reached after 30-70, 70-150, and up to 500 RYGB, and after 30-50, 60-100, and 100-200 LSG. Training curricula, previous laparoscopic experience, and high procedure volume are hallmarks for successful outcomes during the learning curve.


Subject(s)
Gastrectomy/education , Gastric Bypass/education , Laparoscopy/education , Learning Curve , Obesity, Morbid/surgery , Adolescent , Adult , Aged , Bariatric Surgery/adverse effects , Bariatric Surgery/education , Bariatric Surgery/mortality , Bariatric Surgery/standards , Clinical Competence/standards , Clinical Competence/statistics & numerical data , Female , Gastrectomy/mortality , Gastrectomy/standards , Gastrectomy/statistics & numerical data , Gastric Bypass/mortality , Gastric Bypass/standards , Gastric Bypass/statistics & numerical data , Humans , Laparoscopy/mortality , Laparoscopy/standards , Laparoscopy/statistics & numerical data , Male , Middle Aged , Morbidity , Obesity, Morbid/epidemiology , Obesity, Morbid/mortality , Operative Time , Postoperative Complications/epidemiology , Postoperative Complications/mortality , Reference Standards , Retrospective Studies , Treatment Outcome , Weight Loss , Young Adult
14.
Rev Gastroenterol Mex ; 82(2): 134-155, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-28318706

ABSTRACT

This is the first Latin American Consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) regarding special situations in patients with inflammatory bowel disease (IBD). The aim of this consensus is to raise awareness in the medical community in all Latin American countries with respect to pregnancy, vaccinations, infections, neoplasms, including colorectal cancer, and pediatric issues in patients with IBD.


Subject(s)
Inflammatory Bowel Diseases/therapy , Adult , Child , Colitis, Ulcerative/complications , Colitis, Ulcerative/therapy , Consensus , Crohn Disease/complications , Crohn Disease/therapy , Female , Humans , Inflammatory Bowel Diseases/complications , Latin America , Male , Pregnancy
15.
J Dent Res ; 94(4): 584-93, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25666817

ABSTRACT

Matrix metalloproteinase 20 (MMP-20), widely regarded as tooth specific, participates with MMP-2 in processing dentin sialophosphoprotein (DSPP) into dentin sialoprotein, dentin phosphoprotein, and dentin glycoprotein. In biochemical system, MMP-2, MMP-3, and MMP-9 bind with high affinity to, and are activated by, specific small integrin-binding ligand N-linked glycoproteins (SIBLINGs): bone sialoprotein, osteopontin, and dentin matrix protein 1, respectively. Subsequent reports documented possible biological relevance of SIBLING-MMP interaction in vivo by showing that SIBLINGs are always coexpressed with their MMP partners. However, the cognate MMPs for 2 other SIBLINGs-DSPP and matrix extracellular phosphogylcoprotein-are yet to be identified. Our goal was to investigate MMP-20 expression and to explore preliminary evidence of its interaction with DSPP in oral squamous cell carcinomas (OSCCs). Immunohistochemistry analysis of sections from 21 cases of archived human OSCC tissues showed immunoreactivity for MMP-20 in 18 (86%) and coexpression with DSPP in all 15 cases (71%) positive for DSPP. Similarly, 28 (93%) of 30 cases of oral epithelial dysplasia were positive for MMP-20. Western blot and quantitative real-time polymerase chain reaction analysis on OSCC cell lines showed upregulation of MMP-20 protein and mRNA, respectively, while immunofluorescence showed coexpression of MMP-20 and DSPP. Colocalization and potential interaction of MMP-20 with dentin sialoprotein was confirmed by coimmunoprecipitation and mass spectrometry analysis of immunoprecipitation product from OSCC cell lysate, and in situ proximity ligation assays. Significantly, results of chromatin immunoprecipation revealed a 9-fold enrichment of DSPP at MMP-20 promoter-proximal elements. Our data provide evidence that MMP-20 has a wider tissue distribution than previously acknowledged. MMP-20-DSPP specific interaction, excluding other MMP-20-SIBLING pairings, identifies MMP-20 as DSPP cognate MMP. Furthermore, the strong DSPP enrichment at the MMP-20 promoter suggests a regulatory role in MMP-20 transcription. These novel findings provide the foundation to explore the mechanisms and significance of DSPP-MMP-20 interaction in oral carcinogenesis.


Subject(s)
Carcinoma, Squamous Cell/chemistry , Extracellular Matrix Proteins/analysis , Matrix Metalloproteinase 20/analysis , Mouth Neoplasms/chemistry , Phosphoproteins/analysis , Sialoglycoproteins/analysis , Cell Line, Tumor , Cell Nucleus/chemistry , Cytoplasm/chemistry , Extracellular Matrix Proteins/genetics , Humans , Integrin-Binding Sialoprotein/analysis , Keratinocytes/chemistry , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 20/genetics , Matrix Metalloproteinase 3/analysis , Matrix Metalloproteinase 9/analysis , Osteopontin/analysis , Phosphoproteins/genetics , Precancerous Conditions/chemistry , Promoter Regions, Genetic/genetics , Sialoglycoproteins/genetics , Transcription, Genetic/genetics
16.
Ann Oncol ; 24(8): 2043-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23609186

ABSTRACT

BACKGROUND: The aim of the present study was to demonstrate that radical hysterectomy (RH) leads to improved survival outcomes in FIGO stage IB2-IIB cervical cancer when compared with standard brachytherapy (BCT) after identical external beam chemoradiation (EBRT-CT). PATIENTS AND METHODS: EBRT-CT treatment consisted of six courses of cisplatin at 40 mg/m² and gemcitabine at 125 mg/m² per week concurrent with 50.4 Gy of radiation. In the BCT arm, EBRT-CT was followed by BCT to reach a point A dose of 85 Gy, whereas in the experimental arm, a type III RH with bilateral pelvic lymph node dissection and para-aortic lymph node sampling (RH) was carried out within 4-6 weeks after EBRT-CT. RESULTS: Between May 2004 and June 2009, 211 patients were enrolled (BCT, 100 and RH, 111). At a median follow-up time of 36 months (3-80), progression-free survival (PFS) and overall survival (OS) rates were similar in both the arms. PFS rates were 74.8% and 71.7% in the BCT and RH arms [HR 0.6516 (95% confidence interval (CI) 0.3504-1.2116)], P = 0.186. OS rates were 76.3% in the BCT versus 74.5% in the surgical arm [HR 0.6981 (95% CI 0.3106-1.3439)], P = 0.236. No differences were observed in the pattern of local and systemic failures. CONCLUSIONS: This study failed to demonstrate that RH after EBRT-CT is superior to standard BCT.


Subject(s)
Brachytherapy , Cisplatin/therapeutic use , Deoxycytidine/analogs & derivatives , Hysterectomy , Uterine Cervical Neoplasms , Adult , Aged , Chemoradiotherapy , Deoxycytidine/therapeutic use , Disease-Free Survival , Female , Humans , Middle Aged , Radiation-Sensitizing Agents/therapeutic use , Survival , Treatment Outcome , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/radiotherapy , Uterine Cervical Neoplasms/surgery , Young Adult , Gemcitabine
17.
Breast ; 19(1): 50-4, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19945878

ABSTRACT

BACKGROUND: The BCRF II study presents a systematic review of the norms, recommendations and guidelines that are considered medical care standards (MCS) for breast cancer in 12 Latin American and Caribbean countries. Three key questions from the BCRF I survey data on early detection and diagnosis are presented to identify implementation practice patterns related to MCS. METHODS: Information related to MCS was requested from governmental health authorities, cancer institutes, and national scientific and professional societies in 12 Latin American and Caribbean countries. Documents received were reviewed by breast cancer experts from each respective country. Three key survey questions from the BCRF I survey on early detection and diagnosis were reprocessed to provide information related to implementation practice of existing MCS. RESULTS: All countries included in the BCRF II study had medical care standards (MCS) whether published by governmental authorities, national professional or scientific associations, cancer institutes, or adoption of international MCS. Experts reported different practice patterns at a Country level versus a Center level. Overall, 85% of the experts reported that less than 50% of the women with no symptoms undergo a mammography at the Country level compared to 43% at the Center level. For diagnostic suspicion of breast cancer, 80% of experts considered the diagnostic suspicion at a Country level to come from the patient compared to 50% at a Center level. About 30% of patients waited for more than 3 months for a diagnosis at the Country level compared to 7% at the Center level. CONCLUSION: All the Latin America and Caribbean countries in the study reported the use of similar MCS for breast cancer care. The reported difference between care practiced at a Country level versus a Center level suggests the challenge is not in generating new MCS, but in implementing policies and control mechanisms for compliance with existing MCS, guaranteeing their applicability to all populations.


Subject(s)
Breast Neoplasms/epidemiology , Health Plan Implementation/organization & administration , Health Services Accessibility/organization & administration , Mass Screening/organization & administration , Women's Health Services/organization & administration , Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Caribbean Region/epidemiology , Female , Health Plan Implementation/standards , Health Services Accessibility/standards , Humans , Latin America/epidemiology , Male , Mass Screening/standards , Medical Oncology/organization & administration , Practice Guidelines as Topic , Quality Indicators, Health Care/organization & administration , Socioeconomic Factors , Women's Health , Women's Health Services/standards
18.
Rev Esp Quimioter ; 19(2): 161-6, 2006 Jun.
Article in Spanish | MEDLINE | ID: mdl-16964334

ABSTRACT

Recently, there has been a marked increase in human papillomavirus (HPV) infection, and the etiological relationship between some HPV genotypes and genital cancer has been confirmed. Therefore, we used current molecular biology techniques to evaluate the prevalence of these viruses and their genotype in genital samples. We processed 401 genital samples from 281 women and 120 men, all with a diagnosis compatible with HPV infection. Virus was detected using PCR, and positive samples were typed using an array technique which enabled us to detect the 35 most common types of mucous-associated HPV. Of the 401 patients studied, 185 (46.1%) were positive, and only one type of HPV was detected in 133 cases. We found that 41.6% of the women and 56.7% of the men were positive. A total of 260 HPVs were typed; 154 were high oncogenic risk. They infected 16 men (23.5%) and 88 women (75.2%). The difference was statistically significant (p<0.001). Type 6 HPV was the most frequently detected en 64 cases, followed by HVP 16 in 52 cases. We found a 46% prevalence of HPV infection. More than half of these patients were infected by high-risk HPV. The presence of high-risk HPV was significantly higher in women.


Subject(s)
Papillomaviridae/isolation & purification , Papillomavirus Infections/virology , Adolescent , Adult , Female , Genital Diseases, Female/virology , Genital Diseases, Male/virology , Humans , Male , Middle Aged , Papillomaviridae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...